Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on March 5, 2025, the Compensation Committee of Acadia’s Board of Directors (the "Committee") granted inducement awards consisting of ...
Cars18d
2025 GMC Acadia
Related: 2024 GMC Acadia Review: Distinctive Looks ... Pricing (including $1,395 destination fee) is as follows: Riding on 18-inch wheels, the standard Elevation trim level also boasts a hands ...
ETF Daily News25d
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $70.22 Consensus Target Price from Brokerages
KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a research report on Tuesday, January 7th.
ACADIA Pharmaceuticals (ACAD) Receives a Rating Update from a Top Analyst
In a report released today, Charles Duncan from Cantor Fitzgerald maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report), ...
ACADIA Pharmaceuticals (ACAD) Receives a Hold from Bank of America Securities
Bank of America Securities analyst Tazeen Ahmad maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report) today. The ...